These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26950826)

  • 1. Emerging immunotherapy for the treatment of esophageal cancer.
    Jackie Oh S; Han S; Lee W; Lockhart AC
    Expert Opin Investig Drugs; 2016 Jun; 25(6):667-77. PubMed ID: 26950826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for esophageal cancer: a 2019 update.
    Schizas D; Charalampakis N; Kole C; Mylonas KS; Katsaros I; Zhao M; Ajani JA; Psyrri A; Karamouzis MV; Liakakos T
    Immunotherapy; 2020 Feb; 12(3):203-218. PubMed ID: 32208794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A good start of immunotherapy in esophageal cancer.
    Zhao Q; Yu J; Meng X
    Cancer Med; 2019 Aug; 8(10):4519-4526. PubMed ID: 31231980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising immunotherapies for esophageal cancer.
    Tanaka T; Nakamura J; Noshiro H
    Expert Opin Biol Ther; 2017 Jun; 17(6):723-733. PubMed ID: 28366014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy for esophageal carcinoma].
    Yamana H
    Nihon Geka Gakkai Zasshi; 2002 Apr; 103(4):376-80. PubMed ID: 11993228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.
    Alsina M; Moehler M; Lorenzen S
    Oncol Res Treat; 2018; 41(5):266-271. PubMed ID: 29705786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
    Park R; Williamson S; Kasi A; Saeed A
    Anticancer Res; 2018 Oct; 38(10):5569-5580. PubMed ID: 30275174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for oesophagogastric cancer.
    Davidson M; Chau I
    Expert Opin Biol Ther; 2016 Oct; 16(10):1197-207. PubMed ID: 27409159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in Gynecologic Cancers: Are We There Yet?
    Pakish JB; Jazaeri AA
    Curr Treat Options Oncol; 2017 Aug; 18(10):59. PubMed ID: 28840453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review).
    Lampis A; Ratti M; Ghidini M; Mirchev MB; Okuducu AF; Valeri N; Hahne JC
    Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
    Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
    Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic strategies for treating esophageal adenocarcinoma: the potential of dendritic cell immunotherapy and combinatorial regimens.
    Milano F; Krishnadath KK
    Hum Immunol; 2008 Oct; 69(10):614-24. PubMed ID: 18703104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancer.
    Toh U; Sudo T; Kido K; Matono S; Sasahara H; Mine T; Tanaka T; Sueyoshi S; Fujita H; Shirouzu K; Yamana H
    Int J Clin Oncol; 2002 Dec; 7(6):372-5. PubMed ID: 12494255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
    Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
    Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
    Bolm L; Käsmann L; Paysen A; Karapetis C; Rades D; Wellner UF; Keck T; Watson DI; Hummel R; Hussey DJ
    Anticancer Res; 2018 Jun; 38(6):3231-3242. PubMed ID: 29848670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The swinging pendulum of cancer immunotherapy personalization.
    Abraham TS; Snook AE
    Per Med; 2017 May; 14(3):259-270. PubMed ID: 29767586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging immunotherapies in ovarian cancer.
    Ojalvo LS; Nichols PE; Jelovac D; Emens LA
    Discov Med; 2015 Sep; 20(109):97-109. PubMed ID: 26463091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Checkpoint Inhibitors in Esophageal Cancers: are we Finally Finding the Right Path in the Mist?
    Vivaldi C; Catanese S; Massa V; Pecora I; Salani F; Santi S; Lencioni M; Vasile E; Falcone A; Fornaro L
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapeutic Approaches to Biliary Cancer.
    Shah UA; Nandikolla AG; Rajdev L
    Curr Treat Options Oncol; 2017 Jul; 18(7):44. PubMed ID: 28660602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.